ADAMTS9 regulates skeletal muscle insulin sensitivity through extracellular matrix alterations

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Anne-Sofie Graae, Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Niels Grarup, The Novo Nordisk Foundation Center for Basic Metabolic Research, Section on Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Rasmus Ribel-Madsen, Steno Diabetes Center, Gentofte, Denmark.
  • ,
  • Sara H Lystbæk, Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Trine Boesgaard, The Novo Nordisk Foundation Center for Basic Metabolic Research, Section on Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Harald Staiger, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls University Tübingen, Tübingen, Germany.
  • ,
  • Andreas Fritsche, Department of Internal Medicine IV, University Hospital of Tübingen, Tübingen, Germany.
  • ,
  • Niels Wellner, The Lundbeck Foundation Research Center MIND, Danish Research Institute of Translational Neuroscience, Nordic EMBL Partnership for Molecular Medicine, Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • ,
  • Karolina Sulek, The Novo Nordisk Foundation Center for Basic Metabolic Research, Section on Integrative Physiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Mads Kjolby
  • Marie Balslev Backe, Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Sabina Chubanava, The Novo Nordisk Foundation Center for Basic Metabolic Research, Section on Integrative Physiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Clara Prats, Xlab, Center for Healthy Aging, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
  • ,
  • Annette K Serup, c Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science , University of Copenhagen , Copenhagen , Denmark.
  • ,
  • Jesper B Birk, c Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science , University of Copenhagen , Copenhagen , Denmark.
  • ,
  • Johanne Dubail, Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • ,
  • Linn Gillberg, Steno Diabetes Center, Gentofte, Denmark.
  • ,
  • Sara G Vienberg, The Novo Nordisk Foundation Center for Basic Metabolic Research, Section on Integrative Physiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Anders Nykjær
  • Bente Kiens, c Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science , University of Copenhagen , Copenhagen , Denmark.
  • ,
  • Jørgen F P Wojtaszewski, c Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science , University of Copenhagen , Copenhagen , Denmark.
  • ,
  • Steen Larsen, Xlab, Center for Healthy Aging, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
  • ,
  • Suneel S Apte, Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • ,
  • Hans-Ulrich Häring, Department of Internal Medicine IV, University Hospital of Tübingen, Tübingen, Germany.
  • ,
  • Allan Vaag, Cardiovascular and Metabolic Disease Translational Medicine Unit, Early Clinical Development, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • ,
  • Björn Zethelius, Department of Public Health and Caring Services/Geriatrics, Uppsala University, Uppsala, Sweden.
  • ,
  • Oluf Pedersen, The Novo Nordisk Foundation Center for Basic Metabolic Research, Section on Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Jonas T Treebak, Section for Integrative Physiology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark holst@sund.ku.dk torben.hansen@sund.ku.dk jttreebak@sund.ku.dk.
  • ,
  • Torben Hansen, Section for Metabolic Genetics, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark holst@sund.ku.dk torben.hansen@sund.ku.dk jttreebak@sund.ku.dk.
  • ,
  • Birgitte Holst, Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark holst@sund.ku.dk torben.hansen@sund.ku.dk jttreebak@sund.ku.dk.
OriginalsprogEngelsk
TidsskriftDiabetes
Vol/bind68
Nummer3
Sider (fra-til)502-514
Antal sider13
ISSN0012-1797
DOI
StatusUdgivet - 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 141513939